LIGAND PHARMACEUTICALS INC Insider Trading for June 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LIGAND PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LIGAND PHARMACEUTICALS INC for June 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 12 2020 | LGND | LIGAND PHARMACEUTI ... | Sabba Stephen L | Director | Option Exercise | A | 117.58 | 2,468 | 290,187 | 2,468 | |
Jun 12 2020 | LGND | LIGAND PHARMACEUTI ... | Sabba Stephen L | Director | Grant | A | 0.00 | 831 | 0 | 24,431 | 23.6 K to 24.4 K (+3.52 %) |
Jun 12 2020 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Option Exercise | A | 117.58 | 2,468 | 290,187 | 2,468 | |
Jun 12 2020 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Grant | A | 0.00 | 831 | 0 | 68,034 | 67.2 K to 68 K (+1.24 %) |
Jun 12 2020 | LGND | LIGAND PHARMACEUTI ... | Boyce Sarah | Director | Option Exercise | A | 117.58 | 2,468 | 290,187 | 2,468 | |
Jun 12 2020 | LGND | LIGAND PHARMACEUTI ... | Boyce Sarah | Director | Grant | A | 0.00 | 831 | 0 | 2,262 | 1.4 K to 2.3 K (+58.07 %) |
Jun 12 2020 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Option Exercise | A | 117.58 | 2,468 | 290,187 | 2,468 | |
Jun 12 2020 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Grant | A | 0.00 | 831 | 0 | 50,305 | 49.5 K to 50.3 K (+1.68 %) |
Jun 12 2020 | LGND | LIGAND PHARMACEUTI ... | Gray Nancy Ryan | Director | Option Exercise | A | 117.58 | 2,468 | 290,187 | 2,468 | |
Jun 12 2020 | LGND | LIGAND PHARMACEUTI ... | Gray Nancy Ryan | Director | Grant | A | 0.00 | 831 | 0 | 3,072 | 2.2 K to 3.1 K (+37.08 %) |
Jun 12 2020 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Option Exercise | A | 117.58 | 2,468 | 290,187 | 2,468 | |
Jun 12 2020 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Grant | A | 0.00 | 831 | 0 | 27,208 | 26.4 K to 27.2 K (+3.15 %) |
Jun 12 2020 | LGND | LIGAND PHARMACEUTI ... | LAMATTINA JOHN L | Director | Option Exercise | A | 117.58 | 2,468 | 290,187 | 2,468 | |
Jun 12 2020 | LGND | LIGAND PHARMACEUTI ... | LAMATTINA JOHN L | Director | Grant | A | 0.00 | 831 | 0 | 24,768 | 23.9 K to 24.8 K (+3.47 %) |
Jun 12 2020 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Option Exercise | A | 117.58 | 2,468 | 290,187 | 2,468 | |
Jun 12 2020 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Grant | A | 0.00 | 831 | 0 | 27,190 | 26.4 K to 27.2 K (+3.15 %) |
Jun 05 2020 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | SVP, Gen. Counsel & ... | Sell | S | 118.59 | 11,146 | 1,321,775 | 40,877 | 52 K to 40.9 K (-21.43 %) |